About Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie
Clinical Trials at Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie
During the past decade, Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie"
#1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie
According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie" are
"Castration-Resistant Prostate Cancer" (1 trials), "Kidney Neoplasms" (1 trials), "Muscle-invasive Bladder Cancer" (1 trials), "Prostate Cancer Metastatic" (1 trials) and "Prostatic Neoplasms, Castration-Resistant" (1 trials). Many other conditions were trialed in "Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie
Most popular intervention types in "Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie" are "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Placebo" (3 trials), "Enzalutamide" (2 trials), "Granulocyte colony-stimulating factor (G-CSF)" (1 trials) and "Prednisone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie
The vast majority of trials in "Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie" are
3 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie
Currently, there are NaN active trials in "Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".